bezafibrate has been researched along with geranylgeranyl pyrophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Otero, R; López-Patiño, MA; Míguez, JM; Otero-Rodiño, C; Soengas, JL; Velasco, C | 1 |
| Hoshida, T; Kimura, A; Maeda, A; Mastuda, T; Nishida, S; Takeda, T; Tanabe, K; Tsubaki, M; Yanae, M | 1 |
2 other study(ies) available for bezafibrate and geranylgeranyl pyrophosphate
| Article | Year |
|---|---|
In vitro evidence in rainbow trout supporting glucosensing mediated by sweet taste receptor, LXR, and mitochondrial activity in Brockmann bodies, and sweet taste receptor in liver.
Topics: Animals; Bezafibrate; Chromans; Dose-Response Relationship, Drug; Endocrine System; Glucose; Iridoids; Liver; Liver X Receptors; Mitochondria; Oncorhynchus mykiss; Phlorhizin; Polyisoprenyl Phosphates | 2016 |
Combination treatment with statins and bezafibrate induces myotoxicity via inhibition of geranylgeranyl pyrophosphate biosynthesis and Rho activation in L6 myoblasts and myotube cells.
Topics: Animals; Bezafibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Fibers, Skeletal; Myoblasts; Myotoxicity; Polyisoprenyl Phosphates; Rats; Rhabdomyolysis | 2022 |